Cutaneous and ocular persistent yellowish plaques: a clinicopathological challenge.

Given the findings from dermoscopy and the already histologically confirmed RDD in our patient, a conjunctival biopsy was not considered necessary. In addition, I NRAS i , I KRAS i , I MAP2K1 i and I ARAF i mutations in patients with RDD have recently been identified.[2] Dermoscopy may be a useful diagnostic tool for cutaneous RDD. CPD questions Learning objective To gain up-to-date knowledge on the clinical presentations and management of Rosai-Dorfman disease (RDD) with cutaneous and ocular involvement. [Extracted from the article]